Important provisions have been made to the new FDA Amendments Act directly relating to advertising of prescription drugs: 1) a voluntary user fee program for prescription drug DTC television advertising; and 2) penalties for any DTC advertisement deemed false and misleading.

In a new BioWorld audio conference, speakers Kurt Karst and Dara Katcher Levy, both of Hyman, Phelps & McNamara PC, will offer important facts on how to avoid penalties of up to $500,000 for each violation, how to adhere to new provisions and risks in not using the review process.

"FDA Amendments Act - New DTC User Fees and Potential Penalties" is just $349 per listening site. Scheduled for Dec. 12 from 1 p.m. to 2:30 p.m. EST, it includes presentation handouts and a half-hour Q&A session with the speakers. A conference CD (MP3 format) also is available. For more information or to register, call 800-688-2421 or 404-262-5474. Mention conference code T07484.